Radionuclide therapy of adrenal tumors.
J Surg Oncol
; 106(5): 632-42, 2012 Oct 01.
Article
em En
| MEDLINE
| ID: mdl-22718415
ABSTRACT
Adrenal tumors arising from chromaffin cells will often accumulate radiolabeled metaiodobenzylguanidine (MIBG) and thus are amenable to therapy with I-131 MIBG. More recently, therapy studies have targeted the somatostatin receptors using Lu-177 or Y-90 radiolabeled somatostatin analogs. Because pheochromocytoma (PHEO)/paraganglioma (PGL) and neuroblastoma (NB), which often arise from the adrenals, express these receptors, clinical trials have been performed with these reagents. We will review the experience using radionuclide therapy for targeting PHEO/PGL and NBs.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias das Glândulas Suprarrenais
/
Compostos Radiofarmacêuticos
Limite:
Animals
/
Humans
Idioma:
En
Revista:
J Surg Oncol
Ano de publicação:
2012
Tipo de documento:
Article
País de afiliação:
Estados Unidos